News EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023 Staff September 11, 2023 Iframe sync Post Navigation Previous Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive OfficerNext Veru Reports Clinical Data from the Discontinued ARTEST Study of Enobosarm, Novel Selective Androgen Receptor Targeting Agonist, in AR+ ER+ HER2- Metastatic Breast Cancer More Stories Clinical Trial Healthcare News Pharmaceutical KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 Guidance Staff March 12, 2025 Brain Clinical Trial Diagnostics Healthcare News Optometrist Patient Care The ADDF’s Diagnostics Accelerator Authors New Paper on Ocular Biomarker Landscape, Highlighting Ocular Tests as a Tool for Early Detection of Alzheimer’s Disease Staff March 12, 2025 Cancer Financial Healthcare News Patient Care Olympus Announces Launch of AI-Powered Surgical Planning Tool Through Strategic Partnership with Ziosoft Staff March 12, 2025
